Catalyst Wire Dossier Catalyst Wire Dossier

Glipizide/metformin hydrochloride 5 mg/500 mg tablet (combination)

glipizide/metformin · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glipizide/metformin hydrochloride 5 mg/500 mg tablet (combination), covering 2009-08-18 to 2009-08-18. Get the full timeline:

Most recent: Clinical Trial Update: 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting [Phase 1]

See pricing